Annual Net Income
-$31.54 M
+$10.11 M+24.28%
December 31, 2023
Summary
- As of February 8, 2025, AVTX annual net profit is -$31.54 million, with the most recent change of +$10.11 million (+24.28%) on December 31, 2023.
- During the last 3 years, AVTX annual net income has risen by +$31.96 million (+50.32%).
- AVTX annual net income is now -365.75% below its all-time high of $11.87 million, reached on December 31, 2017.
Performance
AVTX Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
$23.04 M
-$75.43 M-76.60%
September 30, 2024
Summary
- As of February 8, 2025, AVTX quarterly net profit is $23.04 million, with the most recent change of -$75.43 million (-76.60%) on September 30, 2024.
- Over the past year, AVTX quarterly net income has dropped by -$75.43 million (-76.60%).
- AVTX quarterly net income is now -76.60% below its all-time high of $98.46 million, reached on June 30, 2024.
Performance
AVTX Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$7.96 M
+$28.27 M+78.03%
September 30, 2024
Summary
- As of February 8, 2025, AVTX TTM net profit is -$7.96 million, with the most recent change of +$28.27 million (+78.03%) on September 30, 2024.
- Over the past year, AVTX TTM net income has increased by +$28.27 million (+78.03%).
- AVTX TTM net income is now -159.73% below its all-time high of $13.32 million, reached on September 30, 2017.
Performance
AVTX TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
AVTX Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +24.3% | -76.6% | +78.0% |
| 3 y3 years | +50.3% | +334.8% | +80.9% |
| 5 y5 years | +21.2% | +673.6% | +80.9% |
AVTX Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +62.6% | -76.6% | +119.0% | at high | +94.4% |
| 5 y | 5-year | -96.3% | +62.6% | -76.6% | +119.0% | at high | +94.4% |
| alltime | all time | -365.8% | +62.6% | -76.6% | +119.0% | -159.7% | +94.4% |
Avalo Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $23.04 M(-76.6%) | -$7.96 M(-78.0%) |
| Jun 2024 | - | $98.46 M(-181.2%) | -$36.22 M(-74.6%) |
| Mar 2024 | - | -$121.29 M(+1384.9%) | -$142.88 M(+353.0%) |
| Dec 2023 | -$31.54 M(-24.3%) | -$8.17 M(+56.2%) | -$31.54 M(-5.0%) |
| Sep 2023 | - | -$5.23 M(-36.2%) | -$33.19 M(+34.0%) |
| Jun 2023 | - | -$8.19 M(-17.7%) | -$24.77 M(-16.2%) |
| Mar 2023 | - | -$9.96 M(+1.5%) | -$29.56 M(-29.0%) |
| Dec 2022 | -$41.66 M(-50.6%) | -$9.81 M(-407.4%) | -$41.66 M(-18.4%) |
| Sep 2022 | - | $3.19 M(-124.6%) | -$51.04 M(-28.7%) |
| Jun 2022 | - | -$12.99 M(-41.1%) | -$71.63 M(-5.4%) |
| Mar 2022 | - | -$22.05 M(+14.9%) | -$75.75 M(-10.2%) |
| Dec 2021 | -$84.38 M(+32.9%) | -$19.20 M(+10.4%) | -$84.38 M(+4.4%) |
| Sep 2021 | - | -$17.39 M(+1.7%) | -$80.82 M(+5.1%) |
| Jun 2021 | - | -$17.11 M(-44.2%) | -$76.89 M(+5.2%) |
| Mar 2021 | - | -$30.68 M(+96.1%) | -$73.06 M(+15.1%) |
| Dec 2020 | -$63.50 M(+295.1%) | -$15.64 M(+16.2%) | -$63.50 M(+37.3%) |
| Sep 2020 | - | -$13.46 M(+1.3%) | -$46.24 M(+25.7%) |
| Jun 2020 | - | -$13.28 M(-37.1%) | -$36.79 M(+23.7%) |
| Mar 2020 | - | -$21.12 M(-1402.6%) | -$29.74 M(+85.0%) |
| Dec 2019 | -$16.07 M | $1.62 M(-140.4%) | -$16.07 M(-30.9%) |
| Sep 2019 | - | -$4.02 M(-35.5%) | -$23.25 M(-47.0%) |
| Jun 2019 | - | -$6.22 M(-16.5%) | -$43.84 M(+0.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$7.45 M(+34.1%) | -$43.62 M(+8.9%) |
| Dec 2018 | -$40.05 M(-437.4%) | -$5.56 M(-77.4%) | -$40.05 M(+6.6%) |
| Sep 2018 | - | -$24.60 M(+309.5%) | -$37.59 M(-754.9%) |
| Jun 2018 | - | -$6.01 M(+54.7%) | $5.74 M(-42.3%) |
| Mar 2018 | - | -$3.88 M(+25.6%) | $9.95 M(-16.2%) |
| Dec 2017 | $11.87 M(-172.1%) | -$3.09 M(-116.5%) | $11.87 M(-10.9%) |
| Sep 2017 | - | $18.72 M(-1140.9%) | $13.32 M(-215.2%) |
| Jun 2017 | - | -$1.80 M(-8.3%) | -$11.57 M(-13.0%) |
| Mar 2017 | - | -$1.96 M(+19.6%) | -$13.29 M(-19.3%) |
| Dec 2016 | -$16.47 M(+57.0%) | -$1.64 M(-73.4%) | -$16.47 M(-10.9%) |
| Sep 2016 | - | -$6.17 M(+75.0%) | -$18.48 M(+42.1%) |
| Jun 2016 | - | -$3.52 M(-31.4%) | -$13.00 M(+4.9%) |
| Mar 2016 | - | -$5.14 M(+40.9%) | -$12.39 M(+18.1%) |
| Dec 2015 | -$10.49 M(-34.7%) | -$3.65 M(+427.9%) | -$10.49 M(+12.0%) |
| Sep 2015 | - | -$691.10 K(-76.3%) | -$9.36 M(-35.5%) |
| Jun 2015 | - | -$2.91 M(-10.0%) | -$14.51 M(-7.4%) |
| Mar 2015 | - | -$3.24 M(+28.3%) | -$15.67 M(-2.4%) |
| Dec 2014 | -$16.06 M(+23.1%) | -$2.52 M(-56.8%) | -$16.06 M(+18.6%) |
| Sep 2014 | - | -$5.84 M(+43.7%) | -$13.53 M(+75.9%) |
| Jun 2014 | - | -$4.06 M(+12.0%) | -$7.69 M(+112.0%) |
| Mar 2014 | - | -$3.63 M | -$3.63 M |
| Dec 2013 | -$13.04 M | - | - |
FAQ
- What is Avalo Therapeutics annual net profit?
- What is the all time high annual net income for Avalo Therapeutics?
- What is Avalo Therapeutics annual net income year-on-year change?
- What is Avalo Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Avalo Therapeutics?
- What is Avalo Therapeutics quarterly net income year-on-year change?
- What is Avalo Therapeutics TTM net profit?
- What is the all time high TTM net income for Avalo Therapeutics?
- What is Avalo Therapeutics TTM net income year-on-year change?
What is Avalo Therapeutics annual net profit?
The current annual net income of AVTX is -$31.54 M
What is the all time high annual net income for Avalo Therapeutics?
Avalo Therapeutics all-time high annual net profit is $11.87 M
What is Avalo Therapeutics annual net income year-on-year change?
Over the past year, AVTX annual net profit has changed by +$10.11 M (+24.28%)
What is Avalo Therapeutics quarterly net profit?
The current quarterly net income of AVTX is $23.04 M
What is the all time high quarterly net income for Avalo Therapeutics?
Avalo Therapeutics all-time high quarterly net profit is $98.46 M
What is Avalo Therapeutics quarterly net income year-on-year change?
Over the past year, AVTX quarterly net profit has changed by -$75.43 M (-76.60%)
What is Avalo Therapeutics TTM net profit?
The current TTM net income of AVTX is -$7.96 M
What is the all time high TTM net income for Avalo Therapeutics?
Avalo Therapeutics all-time high TTM net profit is $13.32 M
What is Avalo Therapeutics TTM net income year-on-year change?
Over the past year, AVTX TTM net profit has changed by +$28.27 M (+78.03%)